XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Balance at beginning of period (shares) at Dec. 31, 2021   55,356,904      
Balance at beginning of period at Dec. 31, 2021 $ 1,397,038 $ 55 $ 3,099,937 $ 9,068 $ (1,712,022)
Increase (Decrease) in Stockholders' Equity          
Net loss (188,386)       (188,386)
Share-based compensation expense 42,905   42,905    
Issuance of common stock under equity incentive plans (shares)   154,572      
Issuance of common stock under equity incentive plans 2,527 $ 1 2,526    
Unrealized gain (loss) on investments (4,802)     (4,802)  
Foreign currency translation adjustment 0        
Balance at end of period (shares) at Mar. 31, 2022   55,511,476      
Balance at end of period at Mar. 31, 2022 $ 1,249,282 $ 56 3,145,368 4,266 (1,900,408)
Balance at beginning of period (shares) at Dec. 31, 2022 57,854,559 57,854,559      
Balance at beginning of period at Dec. 31, 2022 $ 996,516 $ 58 3,453,066 (3,719) (2,452,889)
Increase (Decrease) in Stockholders' Equity          
Net loss (184,586)       (184,586)
Share-based compensation expense 46,961   46,961    
Issuance of common stock under equity incentive plans (shares)   293,857      
Issuance of common stock under equity incentive plans 1,727 $ 0 1,727    
Unrealized gain (loss) on investments 2,043     2,043  
Foreign currency translation adjustment $ (31)     (31)  
Balance at end of period (shares) at Mar. 31, 2023 58,148,416 58,148,416      
Balance at end of period at Mar. 31, 2023 $ 862,630 $ 58 $ 3,501,754 $ (1,707) $ (2,637,475)